Dezhan HealthCare Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.000x

Dezhan HealthCare Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Dezhan HealthCare Co Ltd (000813) has a cash flow conversion efficiency ratio of 0.000x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-1.39 Million ≈ $-203.66K USD) by net assets (CN¥4.96 Billion ≈ $726.13 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Dezhan HealthCare Co Ltd (1998–2025)

Cash flow conversion efficiency of Dezhan HealthCare Co Ltd from 1998 to 2025. This chart illustrates how Dezhan HealthCare Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Dezhan HealthCare Co Ltd share price for real-time trading data and today's change.

Dezhan HealthCare Co Ltd Cash Flow Conversion Ratio Explained

Dezhan HealthCare Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Dezhan HealthCare Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Dezhan HealthCare Co Ltd ranked by their cash flow conversion efficiency. Also see how much is Dezhan HealthCare Co Ltd worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Zhejiang Huatong Meat Products Co Ltd
SHE:002840
0.142x
Critical Metals Corp. Ordinary Shares
NASDAQ:CRML
-0.067x
Anhui Andeli Department Store Co Ltd
SHG:603031
0.085x
POSCO-Thainox Public Company Limited
BK:INOX
-0.040x
Alkyl Amines Chemicals Limited
NSE:ALKYLAMINE
0.049x
Sichuan Haite High-tech Co Ltd
SHE:002023
0.002x
Xiamen King Long Motor Group Co Ltd
SHG:600686
-0.128x
Beijing CTJ Information Technology Co. Ltd.
SHE:301153
N/A

Annual Cash Flow Conversion Efficiency for Dezhan HealthCare Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Dezhan HealthCare Co Ltd from 1998 to 2025. Review Dezhan HealthCare Co Ltd free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥4.57 Billion
≈ $669.10 Million
CN¥4.72 Million
≈ $691.05K
0.001x +136.56%
2024-12-31 CN¥5.16 Billion
≈ $755.79 Million
CN¥-14.59 Million
≈ $-2.13 Million
-0.003x -111.58%
2023-12-31 CN¥5.24 Billion
≈ $766.99 Million
CN¥127.87 Million
≈ $18.71 Million
0.024x -20.29%
2022-12-31 CN¥5.28 Billion
≈ $773.22 Million
CN¥161.72 Million
≈ $23.66 Million
0.031x +294.75%
2021-12-31 CN¥5.47 Billion
≈ $800.43 Million
CN¥42.41 Million
≈ $6.21 Million
0.008x -94.42%
2020-12-31 CN¥5.95 Billion
≈ $871.12 Million
CN¥827.54 Million
≈ $121.09 Million
0.139x -49.96%
2019-12-31 CN¥5.61 Billion
≈ $821.16 Million
CN¥1.56 Billion
≈ $228.10 Million
0.278x +286.30%
2018-12-31 CN¥5.28 Billion
≈ $772.85 Million
CN¥379.78 Million
≈ $55.57 Million
0.072x -15.02%
2017-12-31 CN¥4.55 Billion
≈ $665.14 Million
CN¥384.64 Million
≈ $56.28 Million
0.085x +21.00%
2016-12-31 CN¥3.75 Billion
≈ $548.97 Million
CN¥262.36 Million
≈ $38.39 Million
0.070x -23.14%
2015-12-31 CN¥1.37 Billion
≈ $200.89 Million
CN¥124.91 Million
≈ $18.28 Million
0.091x -9.86%
2014-12-31 CN¥1.35 Billion
≈ $197.84 Million
CN¥136.47 Million
≈ $19.97 Million
0.101x -16.57%
2013-12-31 CN¥1.41 Billion
≈ $206.33 Million
CN¥170.59 Million
≈ $24.96 Million
0.121x +204.23%
2012-12-31 CN¥415.20 Million
≈ $60.76 Million
CN¥16.51 Million
≈ $2.42 Million
0.040x +197.44%
2011-12-31 CN¥428.93 Million
≈ $62.77 Million
CN¥-17.50 Million
≈ $-2.56 Million
-0.041x +56.93%
2010-12-31 CN¥425.26 Million
≈ $62.23 Million
CN¥-40.29 Million
≈ $-5.90 Million
-0.095x -211.41%
2009-12-31 CN¥423.61 Million
≈ $61.99 Million
CN¥36.03 Million
≈ $5.27 Million
0.085x -27.99%
2008-12-31 CN¥478.64 Million
≈ $70.04 Million
CN¥56.53 Million
≈ $8.27 Million
0.118x +906.90%
2007-12-31 CN¥470.05 Million
≈ $68.78 Million
CN¥-6.88 Million
≈ $-1.01 Million
-0.015x -129.17%
2006-12-31 CN¥450.91 Million
≈ $65.98 Million
CN¥22.62 Million
≈ $3.31 Million
0.050x -87.82%
2005-12-31 CN¥327.22 Million
≈ $47.88 Million
CN¥134.83 Million
≈ $19.73 Million
0.412x +172.81%
2004-12-31 CN¥296.13 Million
≈ $43.33 Million
CN¥44.73 Million
≈ $6.55 Million
0.151x +1313.82%
2003-12-31 CN¥472.51 Million
≈ $69.14 Million
CN¥-5.88 Million
≈ $-860.37K
-0.012x -126.33%
2002-12-31 CN¥676.78 Million
≈ $99.03 Million
CN¥31.98 Million
≈ $4.68 Million
0.047x +145.23%
2001-12-31 CN¥650.49 Million
≈ $95.19 Million
CN¥-67.96 Million
≈ $-9.95 Million
-0.104x -65.03%
2000-12-31 CN¥650.09 Million
≈ $95.13 Million
CN¥-41.16 Million
≈ $-6.02 Million
-0.063x -176.18%
1999-12-31 CN¥639.51 Million
≈ $93.58 Million
CN¥53.15 Million
≈ $7.78 Million
0.083x -49.57%
1998-12-31 CN¥612.87 Million
≈ $89.68 Million
CN¥101.00 Million
≈ $14.78 Million
0.165x --

About Dezhan HealthCare Co Ltd

SHE:000813 China Drug Manufacturers - Specialty & Generic
Market Cap
$917.55 Million
CN¥6.27 Billion CNY
Market Cap Rank
#8913 Global
#2088 in China
Share Price
CN¥2.99
Change (1 day)
+0.67%
52-Week Range
CN¥2.81 - CN¥4.59
All Time High
CN¥13.69
About

Dezhan Healthcare Company Limited engages in the research and development, manufacture, and sale of cardiovascular and cerebrovascular drugs in the People's Republic of China. The company offers atorvastatin calcium tablets, amlodipine-atorvastatin calcium tablets, warfarin sodium tablets, trimetazidine hydrochloride tablets, amiodarone hydrochloride tablets, as well as other drugs, including fam… Read more